I wish simply to make five main points for the committee to consider in conjunction with what you have already seen in the petition. First, I accept that, in November this year, the Cabinet Secretary for Health and Wellbeing agreed publicly, at last, that the current Scottish pharmacy application legislation is deeply flawed and will be revised. He has promised action soon. However, that process of review actually began in June 2013, following an MSP’s meeting with Michael Matheson, the Minister for Public Health, which identified serious problems with the legislation. We are still awaiting action, six months later.
Secondly, although the threat to Benbecula’s GP dispensing has been removed for now, two more practices are threatened with unwelcome applications—one in Drymen and one in Aberfoyle, and there may be a third one in Castletown. If a moratorium on further applications is not applied, other applications will follow; some 40 of 101 dispensing practices in Scotland are at risk. The problems and distress that those unwelcome applications are causing in communities and to staff should not be underestimated.
Thirdly, there is a belief in Government and the pharmaceutical industry that each and every existing pharmacist might be adversely affected by new start-ups. Thus, many pharmacists oppose new pharmacies even outwith their local area, whether they be independent or co-located with a medical practice. Government officials have admitted that the legislation is protecting pharmacists when application decisions are being made, regardless of community input. I have used freedom of information requests to determine dispensing income in every pharmacy in Scotland, and with input from an experienced dispensing practitioner, it is clear to me that rarely do such dangers exist. Some pharmacists will go to extraordinary lengths to protect their existing profit margins. Competition, as advocated by the Office of Fair Trading some years ago and rejected by the Scottish Government at that time could, I believe, save tens of millions of pounds in the Scottish national health service budget.
Fourthly, there is little evidence that those who are involved in negotiating and setting down the pharmacy legislation are prepared to take note of what patients in communities all over Scotland have been telling them for the past five years; namely, that patients demand a say on what they want locally, and having imposed upon them an unwanted pharmacy is definitely not part of that demand. Communities, including Whitlawburn, seek to have independent pharmacies; they should not be denied that choice by other pharmacists outwith the area.
Finally, at present, pharmacy legislation operates in a way that brings huge profits for a few and an impoverished health service for many people in the communities that are affected. It should not matter whether the dispensing and other services are provided by GPs, co-located GP surgeries and pharmacies, or independent pharmacies. Input that seeks to deny or restrain democratic choice must be rejected, whether it comes from Community Pharmacy Scotland or any other body that is associated with the NHS dispensing service to patients. It is time to change the legislation to support patient choice.